Ayad Jaffa to Male
This is a "connection" page, showing publications Ayad Jaffa has written about Male.
Connection Strength
0.434
-
Heteromerization fingerprints between bradykinin B2 and thromboxane TP receptors in native cells. PLoS One. 2019; 14(5):e0216908.
Score: 0.036
-
Analysis of multivariate longitudinal kidney function outcomes using generalized linear mixed models. J Transl Med. 2015 Jun 14; 13:192.
Score: 0.027
-
Novel mechanism of plasma prekallikrein (PK) activation by vascular smooth muscle cells: evidence of the presence of PK activator. J Biol Regul Homeost Agents. 2014 Oct-Dec; 28(4):587-603.
Score: 0.026
-
Creatinine metabolite, HMH (5-hydroxy-1-methylhydantoin; NZ-419), modulates bradykinin-induced changes in vascular smooth muscle cells. J Recept Signal Transduct Res. 2014 Jun; 34(3):195-200.
Score: 0.025
-
Evidence for prostacyclin and cAMP upregulation by bradykinin and insulin-like growth factor 1 in vascular smooth muscle cells. J Recept Signal Transduct Res. 2010 Apr; 30(2):61-71.
Score: 0.019
-
Connective tissue growth factor and susceptibility to renal and vascular disease risk in type 1 diabetes. J Clin Endocrinol Metab. 2008 May; 93(5):1893-900.
Score: 0.017
-
Renal kallikrein: a risk marker for nephropathy in children with sickle cell disease. J Pediatr Hematol Oncol. 2006 Mar; 28(3):147-53.
Score: 0.014
-
Mechanisms through which bradykinin promotes glomerular injury in diabetes. Am J Physiol Renal Physiol. 2005 Mar; 288(3):F483-92.
Score: 0.013
-
Mechanisms of angiotensin II-induced expression of B2 kinin receptors. Am J Physiol Heart Circ Physiol. 2004 Mar; 286(3):H926-32.
Score: 0.013
-
Role of reactive oxygen species in bradykinin-induced proliferation of vascular smooth muscle cells. Biol Res. 2004; 37(3):419-30.
Score: 0.012
-
Plasma prekallikrein: a risk marker for hypertension and nephropathy in type 1 diabetes. Diabetes. 2003 May; 52(5):1215-21.
Score: 0.012
-
Induction of B(1)-kinin receptors in vascular smooth muscle cells: cellular mechanisms of map kinase activation. Hypertension. 2001 Sep; 38(3 Pt 2):602-5.
Score: 0.011
-
Regulation of B(2)-kinin receptors by glucose in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol. 2001 Apr; 280(4):H1537-46.
Score: 0.010
-
Mechanisms by which bradykinin promotes fibrosis in vascular smooth muscle cells: role of TGF-beta and MAPK. Am J Physiol Heart Circ Physiol. 2000 Dec; 279(6):H2829-37.
Score: 0.010
-
Native and modified LDL activate extracellular signal-regulated kinases in mesangial cells. Diabetes. 2000 Dec; 49(12):2160-9.
Score: 0.010
-
Longitudinal Plasma Kallikrein Levels and Their Association With the Risk of Cardiovascular Disease Outcomes in Type 1 Diabetes in DCCT/EDIC. Diabetes. 2020 11; 69(11):2440-2445.
Score: 0.010
-
Role of reactive oxygen species in bradykinin-induced mitogen-activated protein kinase and c-fos induction in vascular cells. Hypertension. 2000 Apr; 35(4):942-7.
Score: 0.010
-
Calcium-calmodulin mediates bradykinin-induced MAPK phosphorylation and c-fos induction in vascular cells. Am J Physiol. 1999 09; 277(3):H1061-8.
Score: 0.009
-
Mechanisms of MAPK activation by bradykinin in vascular smooth muscle cells. Am J Physiol. 1999 08; 277(2):C253-61.
Score: 0.009
-
Cellular distribution of exogenous aprotinin in the rat kidney. Biol Chem. 1998 Oct; 379(10):1271-7.
Score: 0.009
-
Plasma Connective Tissue Growth Factor (CTGF/CCN2) Levels Predict Myocardial Infarction in the Veterans Affairs Diabetes Trial (VADT) Cohort. Diabetes Care. 2018 04; 41(4):840-846.
Score: 0.008
-
Induction of renal kallikrein and renin gene expression by insulin and IGF-I in the diabetic rat. Diabetes. 1997 Dec; 46(12):2049-56.
Score: 0.008
-
Bradykinin induces tubulin phosphorylation and nuclear translocation of MAP kinase in mesangial cells. Am J Physiol. 1997 12; 273(6):F916-24.
Score: 0.008
-
Modulation of renal kallikrein production by dietary protein in streptozotocin-induced diabetic rats. J Am Soc Nephrol. 1996 May; 7(5):721-7.
Score: 0.007
-
Plasma Prekallikrein Is Associated With Carotid Intima-Media Thickness in Type 1 Diabetes. Diabetes. 2016 Feb; 65(2):498-502.
Score: 0.007
-
Inhibition of Sphingosine Kinase 1 Ameliorates Angiotensin II-Induced Hypertension and Inhibits Transmembrane Calcium Entry via Store-Operated Calcium Channel. Mol Endocrinol. 2015 Jun; 29(6):896-908.
Score: 0.007
-
Kinin, a mediator of diabetes-induced glomerular hyperfiltration. Diabetes. 1995 Feb; 44(2):156-60.
Score: 0.007
-
Insulin-like growth factor I produces renal hyperfiltration by a kinin-mediated mechanism. Am J Physiol. 1994 Jan; 266(1 Pt 2):F102-7.
Score: 0.006
-
Altered renal kallikrein and renin gene expression in nephrotic rats and modulation by converting enzyme inhibition. J Clin Invest. 1993 Aug; 92(2):1073-9.
Score: 0.006
-
Involvement of renal cytochromes P450 and arachidonic acid metabolites in diabetic nephropathy. J Biol Regul Homeost Agents. 2013 Jul-Sep; 27(3):693-703.
Score: 0.006
-
Ceacam1 deletion causes vascular alterations in large vessels. Am J Physiol Endocrinol Metab. 2013 Aug 15; 305(4):E519-29.
Score: 0.006
-
Evidence for renal kinins as mediators of amino acid-induced hyperperfusion and hyperfiltration in the rat. J Clin Invest. 1992 May; 89(5):1460-8.
Score: 0.006
-
Effects of diabetes and insulin on expression of kallikrein and renin genes in the kidney. Kidney Int. 1992 Apr; 41(4):789-95.
Score: 0.005
-
Regulation of renal kallikrein synthesis and activation by glucocorticoids. Kidney Int. 1990 Aug; 38(2):212-8.
Score: 0.005
-
Genetic variant in the promoter of connective tissue growth factor gene confers susceptibility to nephropathy in type 1 diabetes. J Med Genet. 2010 Jun; 47(6):391-7.
Score: 0.005
-
Renal kallikrein responses to dietary protein: a possible mediator of hyperfiltration. Kidney Int. 1989 Dec; 36(6):1003-10.
Score: 0.005
-
The effects of diabetes and insulin on colonic tissue kallikrein. Adv Exp Med Biol. 1989; 247B:669-73.
Score: 0.004
-
Abnormal regulation of renal kallikrein in experimental diabetes. Effects of insulin on prokallikrein synthesis and activation. J Clin Invest. 1987 Dec; 80(6):1651-9.
Score: 0.004
-
Pioglitazone inhibits connective tissue growth factor expression in advanced atherosclerotic plaques in low-density lipoprotein receptor-deficient mice. Atherosclerosis. 2007 May; 192(1):85-91.
Score: 0.004
-
Studies of the effects of insulin, bradykinin, and captopril on blood glucose levels of alloxan-diabetic rats. Adv Exp Med Biol. 1986; 198 Pt B:373-8.
Score: 0.004
-
Lipids stimulate the production of 6-keto-prostaglandin f(1alpha) in human dorsal hand veins. Hypertension. 2001 Oct; 38(4):858-63.
Score: 0.003
-
A metabolic fragment of bradykinin, Arg-Pro-Pro-Gly-Phe, protects against the deleterious effects of lipopolysaccharide in rats. J Pharmacol Exp Ther. 2001 Jan; 296(1):71-6.
Score: 0.003
-
Role of kinins in the renal response to enalaprilat in normotensive and hypertensive rats. Hypertension. 1996 Feb; 27(2):235-44.
Score: 0.002
-
Thromboxane A2/prostaglandin H2 receptors in streptozotocin-induced diabetes: effects of insulin therapy in the rat. Prostaglandins. 1993 May; 45(5):427-38.
Score: 0.001
-
Renal kallikrein and hemodynamic abnormalities of diabetic kidney. Diabetes. 1990 Mar; 39(3):299-304.
Score: 0.001
-
Acute and chronic responses of human renal kallikrein and kinins to dietary protein. Am J Physiol. 1989 Nov; 257(5 Pt 2):F718-23.
Score: 0.001
-
Studies of sweat kallikrein in normal human subjects. Adv Exp Med Biol. 1989; 247B:649-55.
Score: 0.001
-
Measurement of glomerular filtration rate and renal plasma flow in the diabetic rat by the single-injection isotopic technique: effects of altered distribution volumes of 51Cr-EDTA and 125I-hippuran. Diabetes Res. 1988 Oct; 9(2):67-72.
Score: 0.001
-
A time-course study of submandibular kallikrein, blood glucose and insulin of alloxan-diabetic and streptozotocin-diabetic rats. Agents Actions. 1984 Dec; 15(5-6):478-81.
Score: 0.001